Indications for the performance of intracranial endovascular neurointerventional procedures: A scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research

Circulation

Volumn 119, Issue 16, 2009, Pages 2235-2239

  Meyers, Philip M ^a   Schumacher, H Christian ^a   Higashida, Randall T ^a   Barnwell, Stanley L ^a   Creager, Mark A ^a   Gupta, Rishi ^a   McDougall, Cameron G ^a   Pandey, Dilip K ^a   Sacks, David ^a   Wechsler, Lawrence R ^a  

^a NONE

Author keywords

AHA Scientific Statments; aneurysm; arteriovenous malformation; cerebral; cerebrovascular; circulation; intracranial; practice guideline; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; SARUPLASE; UROKINASE; WARFARIN;

ANESTHESIA; ANEURYSM RUPTURE; ANGIOPLASTY; ARTERIOVENOUS MALFORMATION; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CARDIOVASCULAR SURGERY; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; COIL EMBOLIZATION; DRUG FATALITY; ENDOVASCULAR SURGERY; FOLLOW UP; HEALTH CARE QUALITY; HEART INFARCTION; HUMAN; INTERVENTION STUDY; INTRACRANIAL STENOSIS; LOW DRUG DOSE; MEDICAL LITERATURE; MEDICAL SOCIETY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RADIOLOGY; RANDOMIZATION; REVIEW; SAFETY; SIDE EFFECT; STENOSIS; STENT; STROKE; SUBARACHNOID HEMORRHAGE; SUDDEN DEATH; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; ARTIFICIAL EMBOLISM; INTRACRANIAL ANEURYSM; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; PRACTICE GUIDELINE; UNITED STATES;

AMERICAN HEART ASSOCIATION; ANGIOPLASTY; CEREBRAL REVASCULARIZATION; EMBOLIZATION, THERAPEUTIC; HUMANS; INTRACRANIAL ANEURYSM; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; STENTS; STROKE; UNITED STATES;

EID: 67249130782     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.192217     Document Type: Review

References (135)

1. Accreditation Council for Graduate Medical Education. ACGME program requirements for fellowship education in endovascular surgical neuroradiology. Available at: http://www.acgme.org/acwebsite/downloads/rrc-progreq/ 422endovascularneuroradiology07012007.pdf. Accessed May 2008.
2. Higashida RT, Hopkins LN, Berenstein A, Halbach VV, Kerber C. Program requirements for residency/fellowship education in neuroendovascular surgery/interventional neuroradiology: a special report on graduate medical education. AJNR Am J Neuroradiol. 2000;21:1153-1159.
3. Creager MA, Goldstone J, Hirshfeld JW Jr, Kazmers A, Kent KC, Lorell BH, Olin JW, Rainer Pauly R, Rosenfield K, Roubin GS, Sicard GA, White CJ, Winters WL Jr, Merli G, Rodgers GP, Tracy CM, Weitz HH. ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on peripheral vascular disease). J Am Coll Cardiol. 2004;44:941-957.
4. Bederson JB, Awad IA, Wiebers DO, Piepgras D, Haley EC Jr, Brott T, Hademenos G, Chyatte D, Rosenwasser R, Caroselli C. Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2000;31: 2742-2750.
5. Kiyohara Y, Ueda K, Hasuo Y, Wada J, Kawano H, Kato I, Sinkawa A, Ohmura T, Iwamoto H, Omae T. Incidence and prognosis of subarachnoid hemorrhage in a Japanese rural community. Stroke. 1989;20: 1150-1155.
6. Sarti C, Tuomilehto J, Salomaa V, Sivenius J, Kaarsalo E, Narva EV, Salmi K, Torppa J. Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke. 1991;22:848-853.
7. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124(pt 2):249-278.
8. Inagawa T, Hirano A. Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol. 1990;34:361-365.
9. McCormick WF, Nofzinger JD. Saccular intracranial aneurysms: an autopsy study. J Neurosurg. 1965;22:155-159.
10. Schievink WI. Intracranial aneurysms [published correction appears in N Engl J Med. 1997;336:1267]. N Engl J Med. 1997;336:28-40.
11. Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, Sternau LL, Torner J, Adams HP Jr, Feinberg W. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:2315-2328.
12. McKissock W, Richardson A, Walsh L. Anterior communicating aneurysms: a trial of conservative and surgical treatment. Lancet. 1965;1: 874-876.
13. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28:660-664.
14. Guglielmi G, Viñuela F, Dion J, Duckwiler G. Electrothrombosis of saccular aneurysms via endovascular approach: part 2: preliminary clinical experience. J Neurosurg. 1991;75:8-14.
15. Guglielmi G, Viñuela F, Sepetka I, Macellari V. Electrothrombosis of saccular aneurysms via endovascular approach: part 1: electrochemical basis, technique, and experimental results. J Neurosurg. 1991;75:1-7.
16. Food and Drug Administration Web Site. Onyx liquid embolic system (Onyx HD-500): h060003. Approved April 11, 2007. Available at: http://www.fda.gov/ cdrh/ode/h060003sum.html. Accessed August 4, 2008.
17. Henkes H, Bose A, Felber S, Miloslavski E, Berg-Dammer E, Kuhne D. Endovascular coil occlusion of intracranial aneurysms assisted by a novel self-expandable nitinol microstent (Neuroform). Interv Neuroradiol. 2002; 8:107-119.
18. Food and Drug Administration Web Site. Neuroform microdelivery stent system: h020002. Issued September 11, 2002. Available at: http://www.fda.gov/ cdrh/ode/H020002sum.html. Accessed August 4, 2008.
19. Higashida RT, Halbach VV, Dowd CF, Juravsky L, Meagher S. Initial clinical experience with a new self-expanding nitinol stent for the treatment of intracranial cerebral aneurysms: the Cordis Enterprise stent. AJNR Am J Neuroradiol. 2005;26:1751-1756.
20. Fiorella D, Woo HH, Albuquerque FC, Nelson PK. Definitive reconstruction of circumferential, fusiform intracranial aneurysms with the pipeline embolization device. Neurosurgery. 2008;62:1115-1120.
21. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360: 1267-1274.
22. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366:809-817.
23. Campi A, Ramzi N, Molyneux AJ, Summers PE, Kerr RS, Sneade M, Yarnold JA, Rischmiller J, Byrne JV. Retreatment of ruptured cerebral aneurysms in patients randomized by coiling or clipping in the International Subarachnoid Aneurysm Trial (ISAT). Stroke. 2007;38: 1538-1544.
24. CARAT Investigators. Rates of delayed rebleeding from intracranial aneurysms are low after surgical and endovascular treatment. Stroke. 2006;37:1437-1442.
25. Wiebers DO, Whisnant JP, Huston J III, Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362: 103-110.
26. Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF. Treatment of unruptured intracranial aneurysms: a nationwide assessment of effectiveness. AJNR Am J Neuroradiol. 2007;28: 146-151.
27. Johnston SC, Dudley RA, Gress DR, Ono L. Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals. Neurology. 1999;52:1799-1805.
28. Raymond J. Trial on Endovascular Aneurysm Management (TEAM). Available at: http://www.teamstudy.org/index.html. Accessed May 28, 2008.
29. Meisel HJ, Mansmann U, Alvarez H, Rodesch G, Brock M, Lasjaunias P. Cerebral arteriovenous malformations and associated aneurysms: analysis of 305 cases from a series of 662 patients. Neurosurgery. 2000;46:793-800.
30. Perata HJ, Tomsick TA, Tew JM Jr. Feeding artery pedicle aneurysms: association with parenchymal hemorrhage and arteriovenous malformation in the brain. J Neurosurg. 1994;80:631-634.
31. Cloft HJ, Kallmes DF, Kallmes MH, Goldstein JH, Jensen ME, Dion JE. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg. 1998;88:436-440.
32. Anxionnat R, de Melo Neto JF, Bracard S, Lacour JC, Pinelli C, Civit T, Picard L. Treatment of hemorrhagic intracranial dissections. Neurosurgery. 2003;53:289-300.
33. Mizutani T, Kojima H, Asamoto S, Miki Y. Pathological mechanism and three-dimensional structure of cerebral dissecting aneurysms. J Neurosurg. 2001;94:712-717.
34. Andersson R. Giant cell arteritis as a cause of death. Clin Exp Rheumatol. 2000;18(suppl 20):S27-S28.
35. Hurst RW, Grossman RI. Neuroradiology of central nervous system vasculitis. Semin Neurol. 1994;14:320-340.
36. Kovoor JM, Jayakumar PN, Srikanth SG, Sampath S. Intracranial infective aneurysms: angiographic evaluation with treatment. Neurol India. 2001;49:262-266.
37. Magge SN, Chen HI, Stiefel MF, Ernst L, Cahill AM, Hurst R, Storm PB. Multiple ruptured cerebral aneurysms in a child with Takayasu arteritis. J Neurosurg Pediatr. 2008;1:83-87.
38. Oh MS, Kim MH, Chu MK, Yu KH, Kim KH, Lee BC. Polyarteritis nodosa presenting with bilateral cavernous internal carotid artery aneurysms. Neurology. 2008;70:405.
39. Statler JD, Slaughter CR, Ronsivalle JA. Human immunodeficiency virus arteriopathy of the adult cerebral circulation. Mil Med. 2007;172: 647-649.
40. American Heart Association. Heart Disease and Stroke Statistics: 2006 Update. Dallas, Tex: American Heart Association; 2006.
41. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke. 1996;27:1459-1466.
42. Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R. Intracranial stenosis in Chinese patients with acute stroke. Neurology. 1998;50: 812-813.
43. Inzitari D, Hachinski VC, Taylor DW, Barnett HJ. Racial differences in the anterior circulation in cerebrovascular disease: how much can be explained by risk factors? Arch Neurol. 1990;47:1080-1084.
44. Resch JA, Okabe N, Loewenson RB, Kimoto K, Katsuki S, Baker AB. Pattern of vessel involvement in cerebral atherosclerosis: a comparative study between a Japanese and Minnesota population. J Atheroscler Res. 1969;9:239-250.
45. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke. 1996; 27:1974-1980.
46. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke. 1995;26:14-20.
47. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke. 1986;17:648-655.
48. Craig DR, Meguro K, Watridge C, Robertson JT, Barnett HJ, Fox AJ. Intracranial internal carotid artery stenosis. Stroke. 1982;13: 825-828.
49. Wong KS, Li H, Lam WW, Chan YL, Kay R. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke. 2002;33:532-536.
50. Segura T, Serena J, Castellanos M, Teruel J, Vilar C, Dávalos A. Embolism in acute middle cerebral artery stenosis. Neurology. 2001;56: 497-501.
51. Akins PT, Pilgram TK, Cross DT III, Moran CJ. Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke. 1998;29:433-438.
52. Marzewski DJ, Furlan AJ, St Louis P, Little JR, Modic MT, Williams G. Intracranial internal carotid artery stenosis: longterm prognosis. Stroke. 1982;13:821-824.
53. Borozan PG, Schuler JJ, LaRosa MP, Ware MS, Flanigan DP. The natural history of isolated carotid siphon stenosis. J Vasc Surg. 1984;1: 744-749.
54. Wechsler LR, Kistler JP, Davis KR, Kaminski MJ. The prognosis of carotid siphon stenosis. Stroke. 1986;17:714-718.
55. Bogousslavsky J. Prognosis of carotid siphon stenosis. Stroke. 1987; 18:537.
56. Corston RN, Kendall BE, Marshall J. Prognosis in middle cerebral artery stenosis. Stroke. 1984;15:237-241.
57. Feldmeyer JJ, Merendaz C, Regli F. Symptomatic stenoses of the middle cerebral artery [in French]. Rev Neurol (Paris). 1983;139:725-736.
58. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the middle cerebral artery. Stroke. 1986;17: 1112-1120.
59. Moufarrij NA, Little JR, Furlan AJ, Leatherman JR, Williams GW. Basilar and distal vertebral artery stenosis: long-term follow-up. Stroke. 1986;17:938-942.
60. Pessin MS, Gorelick PB, Kwan ES, Caplan LR. Basilar artery stenosis: middle and distal segments. Neurology. 1987;37:1742-1746.
61. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, Pessin MS, Weichel E, Sila CA, Furlan AJ, Kargman DE, Sacco RL, Wityk RJ, Ford G, Fayad PB, for the Warfarin-Aspirin Symptomatic Intracranial Disease Study Group. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology. 1995;45:1488-1493.
62. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology. 2000; 55:490-497.
63. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352: 1305-1316.
64. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563.
65. SSYLVIA Study Investigators. Stenting of Symptomatic Athero-sclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35:1388-1392.
66. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kühne D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology. 2005;47:222-228.
67. Food and Drug Administration (FDA), Center for Devices and Radiological Health. Wingspan Stent System With Gateway PTA Balloon Catheter: h050001. Approved August 3, 2005. Available at: http://www.Fda.Gov/cdrh/ode/h050001sum. html. Accessed May 28, 2008.
68. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, Do HM. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke. 2006;37:1016-1020.
69. Cruz-Flores S, Diamond AL. Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev. 2006;3:CD004133.
70. Abou-Chebl A, Krieger DW, Bajzer CT, Yadav JS. Intracranial angioplasty and stenting in the awake patient. J Neuroimaging. 2006;16: 216-223.
71. Terada T, Tsuura M, Matsumoto H, Masuo O, Tsumoto T, Yamaga H, Ohura Y, Itakura T. Hemorrhagic complications after endovascular therapy for atherosclerotic intracranial arterial stenoses. Neurosurgery. 2006;59:310-318.
72. Abruzzo TA, Tong FC, Waldrop AS, Workman MJ, Cloft HJ, Dion JE. Basilar artery stent angioplasty for symptomatic intracranial atheroocclusive disease: complications and late midterm clinical outcomes. AJNR Am J Neuroradiol. 2007;28:808-815.
73. Jiang WJ, Du B, Leung TW, Xu XT, Jin M, Dong KH. Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement. Radiology. 2007;243:188-197.
74. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N. Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis. Neurology. 2007;68:856-858.
75. Steinfort B, Ng PP, Faulder K, Harrington T, Grinnell V, Sorby W, Morgan MK. Midterm outcomes of paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses. J Neurosurg. 2007;106:222-225.
76. Turk AS, Ahmed A, Niemann DB, Aagaard-Kienitz B, Brooks N, Levine RL. Utilization of self-expanding stents in the treatment of intracranial atherosclerotic disease in the distal small cerebral vessels. Neuroradiology. 2007;49:659-663.
77. Wojak JC, Dunlap DC, Hargrave KR, DeAlvare LA, Culbertson HS, Connors JJ III. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol. 2006;27:1882-1892.
78. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37:2562-2566.
79. Mazighi M, Yadav JS, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke. 2008;39: 1766-1769.
80. Food and Drug Administration. Notice of humanitarian device exemption (HDE) for Neurolink(r) system. Available at: http://www.fda. gov/cdrh/pdf/h010004a.pdf. Accessed February 1, 2005.
81. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Hanel RA, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38:881-887.
82. Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery. 2007;61:644-650.
83. Zaidat OO, Klucznik R, Alexander MJ, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Lynn MJ, Chimowitz M; NIH Multi-Center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008;70:1518-1524.
84. Chimowitz MI. Intracranial stents for arterial stenosis (grant number 5k24ns050307-03). Available at: http://crisp.Cit.Nih.Gov/crisp/crisp-lib. Getdoc?Textkey=7153508&p-grant-num=5k24ns050307-03&p-query=&ticket= 42041844&p-audit-session-id=254805344&p-keywords=. Accessed August 8, 2007.
85. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577-617.
86. Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-Pa Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
87. Qureshi AI, Suri MF, Nasar A, He W, Kirmani JF, Divani AA, Prestigiacomo CJ, Low RB. Thrombolysis for ischemic stroke in the United States: data from National Hospital Discharge Survey 1999-2001. Neurosurgery. 2005;57:647-654.
88. Qureshi AI, Kirmani JF, Sayed MA, Siddiqui AM, Safdar A, Pande RU, Ahmed S, Ferguson R, Hershey LA, Qazi KJ. Buffalo metropolitan area and Erie County stroke study: rationale, design, and methods. Neuroepidemiology. 2004;23:289-298.
89. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
90. Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, Calleja S, Garami Z, Khan K, Akhtar N, O'Rourke F, Shuaib A, Demchuk AM, Alexandrov AV; CLOTBUST Investigators. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke. 2007;38: 69-74.
91. Mandava P, Kent TA. Intra-arterial therapies for acute ischemic stroke. Neurology. 2007;68:2132-2139.
92. Schellinger PD, Hacke W. Intra-arterial thrombolysis is the treatment of choice for basilar thrombosis: pro. Stroke. 2006;37:2436-2437.
93. Ford GA. Intra-arterial thrombolysis is the treatment of choice for basilar thrombosis: con. Stroke. 2006;37:2438-2439.
94. Powers WJ. Intra-arterial thrombolysis for basilar artery thrombosis: trial it. Stroke. 2007;38:704-706.
95. Smith WS. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke. 2007;38:701-703.
96. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators: Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29:4-11.
97. Ducrocq X, Bracard S, Taillandier L, Anxionnat R, Lacour JC, Guillemin F, Debouverie M, Bollaert PE. Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke. J Neuroradiol. 2005;32:26-32.
98. Inoue T, Kimura K, Minematsu K, Yamaguchi T; Japan Multicenter Stroke Investigator's Collaboration. A case-control analysis of intra-arterial urokinase thrombolysis in acute cardioembolic stroke. Cerebrovasc Dis. 2005;19:225-228.
99. Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, Stewart-Wynne EG, Rosen D, McNeil JJ, Bladin CF, Chambers BR, Herkes GK, Young D, Donnan GA. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis. 2005;20: 12-17.
100. Qureshi AI, Siddiqui AM, Kim SH, Hanel RA, Xavier AR, Kirmani JF, Suri MF, Boulos AS, Hopkins LN. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol. 2004;25:322-328.
101. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists [published corrections appear in Stroke. 2007;38:e38 and 2007;38:e96]. Stroke. 2007;38:1655-1711.
102. Qureshi AI, Kirmani JF, Siddiqui AM, Hanel RA, Kim SH, Hopkins LN. Outcomes in acute ischemic stroke patients without angiographically documented arterial occlusion. J Neuroimaging. 2005;15: 37-42.
103. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R Jr, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
104. Tomsick TA. Intravenous thrombolysis for acute ischemic stroke. J Vasc Interv Radiol. 2004;15:S67-S76.
105. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598-2605.
106. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004;35:904-911.
107. Tomsick T, Broderick J, Carrozella J, Khatri P, Hill M, Palesch Y, Khoury J; Interventional Management of Stroke II Investigators. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol. 2008;29:582-587.
108. IMS III. Interventional Management of Stroke (IMS) III trial Web page. Available at: http://clinicaltrials.Gov/ct2/show/nct00359424?Term= interventional=stroke=trial&rank=1. Accessed May 28, 2008.
109. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke [published correction appears in Stroke. 2003;34:2774]. Stroke. 2003;34:e109-e137.
110. Schumacher HC, Meyers PM, Yavagal DR, Harel NY, Elkind MS, Mohr JP, Pile-Spellman J. Endovascular mechanical thrombectomy of an occluded superior division branch of the left MCA for acute cardioembolic stroke. Cardiovasc Intervent Radiol. 2003;26:305-308.
111. Yu W, Binder D, Foster-Barber A, Malek R, Smith WS, Higashida RT. Endovascular embolectomy of acute basilar artery occlusion. Neurology. 2003;61:1421-1423.
112. Gobin YP, Starkman S, Duckwiler GR, Grobelny T, Kidwell CS, Jahan R, Pile-Spellman J, Segal A, Vinuela F, Saver JL. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke. 2004;35:2848-2854.
113. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP, Frei D, Grobelny T, Hellinger F, Huddle D, Kidwell C, Koroshetz W, Marks M, Nesbit G, Silverman IE; Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39:1205-1212.
114. Phatouros CC, Higashida RT, Malek AM, Smith WS, Mully TW, DeArmond SJ, Dowd CF, Halbach VV. Endovascular stenting of an acutely thrombosed basilar artery: technical case report and review of the literature. Neurosurgery. 1999;44:667-673.
115. Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke. 2002;33:2872-2876.
116. Nakano S, Wakisaka S. Mechanical recanalization for acute ischemic stroke. Neurocrit Care. 2004;1:379-383.
117. Levy EI, Ecker RD, Horowitz MB, Gupta R, Hanel RA, Sauvageau E, Jovin TG, Guterman LR, Hopkins LN. Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery. 2006;58: 458-463.
118. Jovin TG, Gupta R, Uchino K, Jungreis CA, Wechsler LR, Hammer MD, Tayal A, Horowitz MB. Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke. 2005;36:2426-2430.
119. Brekenfeld C, Remonda L, Nedeltchev K, v Bredow F, Ozdoba C, Wiest R, Arnold M, Mattle HP, Schroth G. Endovascular neuroradiological treatment of acute ischemic stroke: techniques and results in 350 patients. Neurol Res. 2005;27(suppl 1):S29-S35.
120. Gupta R, Vora NA, Horowitz MB, Tayal AH, Hammer MD, Uchino K, Levy EI, Wechsler LR, Jovin TG. Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke. 2006;37:986-990.
121. Janjua N, Qureshi AI, Kirmani J, Pullicino P. Stent-supported angioplasty for acute stroke caused by carotid dissection. Neurocrit Care. 2006;4:47-53.
122. Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, Pile-Spellman J, Mohr JP; New York Islands AVM Study Investigators. The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003;34:e29-e33.
123. Jessurun GA, Kamphuis DJ, van der Zande FH, Nossent JC. Cerebral arteriovenous malformations in the Netherlands Antilles: high prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin Neurol Neurosurg. 1993;95:193-198.
124. Brown RD Jr, Wiebers DO, Torner JC, O'Fallon WM. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology. 1996;46:949-952.
125. Berman MF, Sciacca RR, Pile-Spellman J, Stapf C, Connolly ES Jr, Mohr JP, Young WL. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000;47:389-396.
126. Stapf C, Mohr JP, Pile-Spellman J, Solomon RA, Sacco RL, Connolly ES Jr. Epidemiology and natural history of arteriovenous malformations. Neurosurg Focus. 2001;11:e1.
127. Ogilvy CS, Stieg PE, Awad I, Brown RD Jr, Kondziolka D, Rosenwasser R, Young WL, Hademenos G. AHA scientific statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001;32:1458-1471.
128. Hartmann A, Mast H, Choi JH, Stapf C, Mohr JP. Treatment of arteriovenous malformations of the brain. Curr Neurol Neurosci Rep. 2007; 7:28-34.
129. Brown RD Jr, Wiebers DO, Torner JC, O'Fallon WM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted Country, Minnesota. J Neurosurg. 1996;85:29-32.
130. Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, Pile-Spellman J, Mohr JP. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66: 1350-1355.
131. Hartmann A, Pile-Spellman J, Stapf C, Sciacca RR, Faulstich A, Mohr JP, Schumacher HC, Mast H. Risk of endovascular treatment of brain arteriovenous malformations. Stroke. 2002;33:1816-1820.
132. Ledezma CJ, Hoh BL, Carter BS, Pryor JC, Putman CM, Ogilvy CS. Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery. 2006;58: 602-611.
133. Newton TH, Cronqvist S. Involvement of dural arteries in intracranial arteriovenous malformations. Radiology. 1969;93:1071-1078.
134. Meyers PM, Halbach VV, Phatouros CP, Dowd CF, Malek AM, Lempert TE, Lefler JE, Higashida RT. Hemorrhagic complications in vein of Galen malformations. Ann Neurol. 2000;47:748-755.
135. Johnston IH, Whittle IR, Besser M, Morgan MK. Vein of Galen malformation: diagnosis and management. Neurosurgery. 1987;20: 747-758.